Expanded Activated Lymphocytes (Beijing Yongtai)

爱可仑赛

Report date: 2025/04/01 09:16:19

Base Information

Drug NameExpanded Activated Lymphocytes (Beijing Yongtai)
Drug Alias Name扩增活化的淋巴细胞（北京永泰生物制品）EAL
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy
Mechanisms of ActionLymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesImmunotech Applied Science Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmunotech Applied Science Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A